ABSTRACT
Objective @#To analyze the survival of patients with malignant mesothelioma, so as to provide insights into the management of malignant mesothelioma.@*Methods @#Totally 36 patients with malignant mesothelioma admitted to Cixi Third People’s Hospital from October 2012 to January 2021 were enrolled, and the demographic features, exposure to asbestos, and diagnosis and treatment were retrospectively reviewed. The survival rate and median survival time were calculated with the life-table method, and the factors affecting the survival rate of malignant mesothelioma were identified using the Kaplan-Meier estimate and log-rank test.@*Results @#The 36 patients with malignant mesothelioma included 6 men ( 16.67% ) and 30 women ( 83.33% ), and had a median age of 61 ( interquartile range, 14 ) years. There were 30 cases with pleural malignant mesothelioma ( 83.33% ) and 6 cases with peritoneal malignant mesothelioma ( 16.67% ), 32 cases ( 88.89% ) with a history of occupational exposure to asbestos, and 26 cases ( 72.22% ) receiving palliative treatment. The 1-, 2- and 3-year cumulative survival rates were 30%, 15% and 3%, respectively, and the median survival time was 0.71 years. In addition, there were no significant differences in the survival period among patients with malignant mesothelioma in terms of gender, age, route of asbestos exposure, duration of asbestos exposure, pathogenic site and treatment regimens ( P>0.05 ).@*Conclusion @#The 36 patients with malignant mesothelioma had a median survival period of 0.71 years, and no association was found between the survival period and asbestos exposure or pathogenic site.
ABSTRACT
@#For patients with dento-maxillofacial deformities who receive orthodontic-orthognathic combined treatment, the conventional treatment approach is preoperative orthodontic-orthognathic surgery-postoperative orthodontics. However, with the development of techniques used in orthodontic and orthognathic treatment, the surgery-first approach (SFA), namely, orthodontic surgery-postoperative orthodontics, has been widely used currently and displays several advantages, such as improving the treatment efficiency and providing patients with more satisfaction. This review provides a brief discussion and review of SFA concerning its development, indications, advantages and disadvantages, outcomes and stability, and the application and research progress of SFA in orthodontic-orthognathic combined treatment for patients with maxillofacial deformity. The literature review results showed that compared with the conventional treatment approach, SFA has relatively strict indications, which usually include patients with skeletal class Ⅱ/Ⅲ malocclusion, skeletal open bite, and bimaxillary protrusion or patients with facial asymmetry but who require little preoperative orthodontic treatment or removal of the compensation of the dental arch, specifically as follows: ①well-aligned to mildly crowded anterior teeth, ②flat to mild curve of Spee, ③normal to mildly proclined/retroclined incisor inclination, ④acceptable arch coordination, ⑤extensive occlusal contact between the upper and lower dentition requiring at least 3 occlusal contacts. Any occlusion that may affect the outcome of surgery or final result of the overall treatment, as well as any disease that may jeopardize the healing process after surgery, is regarded as a contraindication. Furthermore, SFA has potential disadvantages, such as a possible higher incidence of complications, including unstable occlusion and malunion of bones, which still require further research to be confirmed. Most researchers believe that no significant difference occurs between the outcome and stability of the two approaches. However, currently, we still need a sufficient sample size of prospective studies to provide accurate evidence.